| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Equipe Associée à luniversité (EA) 4310/Institut National de la Santé et de la Recherche Médicale Unité 413 (B.L., L.J., S.A., D.A., A.M., L.M., P.B., Y.A., N.C.), Neuronal and Neuroendocrine Differentiation and Communication, European Institute for Peptide Research, and EA 4309 (S.J.), Microvascular Endothelium and Neonatal Brain Lesions, Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23, University of Rouen, F76031 Rouen, France; and Laboratory of Neuroendocrinology and Nutritional and Climatic Environment (F.Z.E.-Y., R.M.), Faculty of Sciences Dhar-El Mahraz, University Sidi Mohamed Ben Abdellah, 30000 Fez, Morocco
Address all correspondence and requests for reprints to: Nicolas Chartrel, Equipe Associée à luniversité 4310/Institut National de la Santé et de la Recherche Médicale Unité 413, Neuronal and Neuroendocrine Differentiation and Communication, European Institute for Peptide Research (LInstitut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), University of Rouen, F76031 Rouen, France. E-mail: nicolas.chartrel{at}univ-rouen.fr.
26RFa is a hypothalamic RFamide neuropeptide that was identified as the endogenous ligand of the orphan G protein-coupled receptor, GPR103, and that stimulates appetite in mice. Up until now, the mechanism of action of 26RFa in the hypothalamic control of food intake remains unknown. The high density of GPR103 in the arcuate nucleus (Arc) prompted us to investigate, in the present study, the effects of 26RFa on the rat neuropeptide Y (NPY)/proopiomelanocortin (POMC) system. Intracerebroventricular injection of 26RFa stimulated NPY expression and release in the basal hypothalamus, whereas it decreased POMC expression and
-MSH release, and these effects were associated with an increase in food intake. A double in situ hybridization procedure indicated that the 26RFa receptor is present in NPY neurons of the Arc, but not in POMC neurons. Central administration of NPY Y1 and Y5 receptor antagonists abolished the inhibitory effects of 26RFa on POMC expression and
-MSH release, and reversed 26RFa-induced food consumption. Finally, 26RFa antagonized the effects of leptin on NPY expression and release, POMC expression and
-MSH release, and food intake. Altogether, the present data demonstrate for the first time that 26RFa exerts its orexigenic activity by stimulating the release of NPY in the Arc, which in turn inhibits POMC neurons by activating the Y1 and Y5 receptors. It is also suggested that the balance 26RFa/leptin is an important parameter in the maintenance of energy homeostasis.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |